Published in Ann Neurol on January 01, 1977
Effects of lymphoma on the peripheral nervous system. J R Soc Med (1994) 1.72
Acute dysautonomia associated with Hodgkin's disease. J Neurol Neurosurg Psychiatry (1986) 1.57
Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry (1991) 1.49
Autoimmune and virus-induced demyelinating diseases. A review. Am J Pathol (1978) 1.39
Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood (2014) 1.06
Chronic inflammatory demyelinating polyneuropathy associated with carcinoma. J Neurol Neurosurg Psychiatry (1996) 1.04
Hodgkin's Lymphoma: A Review of Neurologic Complications. Adv Hematol (2010) 0.97
Lymphoma presenting as mononeuritis multiplex. Postgrad Med J (1981) 0.83
Guillain-Barré syndrome as an atypical manifestation of an esophageal carcinoma. Neurol Sci (2010) 0.79
Guillain-Barré syndrome following severe exertion. J R Soc Med (1991) 0.79
Hodgkin's lymphoma presenting as a complex paraneoplastic neurological syndrome: a case report. J Med Case Rep (2013) 0.78
Paraneoplastic syndromes of the nervous system. West J Med (1985) 0.75
Subacute sensory neuropathy. J Neurol Neurosurg Psychiatry (1982) 0.75
Guillain-Barré syndrome and severe infection following chemotherapy for peripheral T-cell lymphoma: A case report. Oncol Lett (2014) 0.75
Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia. J Clin Pathol (2005) 0.75
Acute inflammatory demyelinating polyradiculoneuropathy following varicella. Postgrad Med J (1987) 0.75
Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report. J Med Case Rep (2014) 0.75
Guillain-Barré syndrome in a patient with chronic lymphocytic leukaemia. Postgrad Med J (1993) 0.75
Treatment of Guillain-Barré syndrome with anti-T cell monoclonal antibodies. J Neurol Neurosurg Psychiatry (1991) 0.75
Human DNA repair genes. Science (2001) 6.11
Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet (1998) 6.04
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12
Management of dizziness in primary care. J Am Board Fam Pract (1994) 3.33
Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains. J Infect Dis (1980) 3.29
Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature (1978) 3.29
Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. Hepatology (1999) 2.64
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol (1981) 2.53
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med (1997) 2.28
The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol (1967) 2.13
Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis (1995) 2.10
A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem (1999) 2.09
Size and physical map of the chromosome of Haemophilus influenzae. J Bacteriol (1989) 2.07
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet (2003) 2.04
Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood (1968) 1.99
Glue-sniffing neuropathy. Arch Neurol (1975) 1.99
Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96
Observation of covalent intermediates in an enzyme mechanism at atomic resolution. Science (2001) 1.92
Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Painful diabetic neuropathy. A morphometric study. Arch Neurol (1976) 1.77
Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc (1969) 1.74
Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology (2005) 1.73
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. J Biol Chem (1990) 1.72
A G-band study of chromosomes in liveborn infants. Ann Hum Genet (1980) 1.72
Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69
Combined use of clinical assessment and d-dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study). J Thromb Haemost (2003) 1.69
Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int Arch Allergy Appl Immunol (1971) 1.68
The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest (1995) 1.63
Muscular dystrophy in young girls. Neurology (1970) 1.60
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
A novel mutation in the P2Y12 receptor and a function-reducing polymorphism in protease-activated receptor 1 in a patient with chronic bleeding. J Thromb Haemost (2014) 1.58
Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain (1975) 1.56
The evolution of emergent computation. Proc Natl Acad Sci U S A (1995) 1.55
Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain. Mamm Genome (2000) 1.54
Giant axonal neuropathy. Pediatrics (1972) 1.53
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (1996) 1.51
Sensory perineuritis. Arch Neurol (1972) 1.51
Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol (1968) 1.50
The thymus in myasthenia gravis. Evidence for altered cell populations. N Engl J Med (1974) 1.50
Cell type-specific markers for human glial and neuronal cells in culture. Lab Invest (1980) 1.49
Histamine suppression of human lymphocyte responses to mitogens. Cell Immunol (1978) 1.48
The acute sensory neuronopathy syndrome: a distinct clinical entity. Ann Neurol (1980) 1.47
Pulmonary pathophysiology in cystic fibrosis. Am Rev Respir Dis (1966) 1.45
Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood (1976) 1.44
Medical Research Council committee draws up guidelines for research into recombinant DNA. Can Med Assoc J (1977) 1.44
Diabetic neuropathy. Ann Neurol (1984) 1.44
Idiopathic polyneuritis after surgery. Arch Neurol (1968) 1.43
Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. Eur J Neurol (2001) 1.41
Chronic urticaria/angioedema and Graves' disease: Coexistence of 2 antireceptor antibody-mediated diseases. J Allergy Clin Immunol (2001) 1.41
Schwann cell proliferation in developing mouse sciatic nerve. A radioautographic study. J Cell Biol (1967) 1.41
Variable transfer of Y-specific sequences in XX males. Nucleic Acids Res (1986) 1.40
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
The process and outcome of a collaborative effort to design and implement a clinician order processing system. Proc Annu Symp Comput Appl Med Care (1992) 1.39
Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis. Neurology (1974) 1.35
Possible impact of audit on chest X-ray requests from surgical wards. Lancet (1983) 1.35
Enhancer complexes located downstream of both human immunoglobulin Calpha genes. J Exp Med (1997) 1.35
Duration of synthesis phase in neuilemma cells in mouse sciatic nerve during degeneration. Exp Neurol (1970) 1.34
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Cervical internal carotid artery dissecting hemorrhage: diagnosis using MR. Radiology (1986) 1.32
Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch Neurol (1974) 1.31
Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med (1968) 1.30
Parastrongylus (=Angiostrongylus) cantonensis now endemic in Louisiana wildlife. J Parasitol (2002) 1.30
Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene. Hum Mol Genet (1998) 1.30
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol (1999) 1.28
Adduct formation between alkali metal ions and divalent metal salicylaldimine complexes having methoxy substituents. A structural investigation. Inorg Chem (2000) 1.27
Experimental allergic neuritis induced by sensitization with galactocerebroside. Science (1979) 1.26
Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol (2000) 1.26
Multiple sclerosis and Sjögren's syndrome: a problem in diagnosis or in definition of two disorders of unknown etiology? Ann Neurol (1990) 1.26
Urorectal septum malformation sequence. Report of six cases and embryological analysis. Am J Dis Child (1987) 1.26
Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. Lab Invest (1978) 1.25
The effect of paternal diet-induced obesity on sperm function and fertilization in a mouse model. Int J Androl (2010) 1.24
Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer (2005) 1.23
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult Scler (2000) 1.23
Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol (1983) 1.23
Hereditary sensory neuropathy. A clinical and ultrastructural study. J Neurol Sci (1970) 1.22
Levels of glycogen and trehalose in Mycobacterium smegmatis and the purification and properties of the glycogen synthetase. J Bacteriol (1973) 1.20
Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell Immunol (1987) 1.20
Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med (1977) 1.20
The prognosis of lupus nephritis. Role of clinical-pathologic correlations. Ann Intern Med (1968) 1.19
Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein. J Immunol (1970) 1.19
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
Mapping the testis determinants by an analysis of Y-specific sequences in males with apparent XX and XO karyotypes and females with XY karyotypes. Nucleic Acids Res (1987) 1.18
Generation of different nucleosome spacing periodicities in vitro. Possible origin of cell type specificity. J Mol Biol (1988) 1.17
Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis. Lancet (1968) 1.17